Long-term efficacy, including halting of radiographicprogression, and safety of etanercept in patients with ankylosing spondylitis

被引：0
|
作者：
Dijkmans, B.
Sridharan, S.
Fatenejad, S.
机构：
[1] Vrije Univ Amsterdam, Dept Rheumatol, Amsterdam, Netherlands
[2] Wyeth Ayerst Res, Res & Dev, Collegeville, MN USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [31] RENAL SAFETY OF LONG TERM NSAID USE IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Kim, Y. E.
    Park, S. Y.
    Ahn, S. M.
    Hong, S.
    Lee, C. K.
    Yoo, B.
    Oh, J. S.
    Kim, Y. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 618 - 619
  • [32] Efficacy of etanercept in ankylosing spondylitis hip lesions
    Wang, Dongxue
    Ma, Li
    Wu, Donghai
    JOINT BONE SPINE, 2011, 78 (05) : 531 - 532
  • [33] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Shaw, Tim
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana Paula
    Pierre-Louis, Bosny J.
    Mease, Philip J.
    RHEUMATOLOGY, 2022, 61
  • [34] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Nash, Peter
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana P.
    Pierre-Louis, Bosny J.
    Shaw, Tim
    Mease, Philip J.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 27 - 27
  • [35] COMPARISON OF LONG-TERM DRUG SURVIVAL OUTCOME WITH ETANERCEPT TREATMENT AND ADALIMUMAB TREATMENT OF ANKYLOSING SPONDYLITIS
    Ruwaard, J.
    I'Ami, M.
    Marsman, A.
    Kneepkens, E.
    van der Horst-Bruinsma, I. E.
    van Denderen, C.
    Nurmohamed, M. T.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 813 - 813
  • [36] Long-Term Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Burmester, Gerd
    Cohen, Stanley
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana Paula
    Pierre-Louis, Bosny
    Shaw, Tim
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3525 - 3527
  • [37] Long-Term Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana P.
    Pierre-Louis, Bosny J.
    Shaw, Tim
    Mease, Philip J.
    SWISS MEDICAL WEEKLY, 2022, 152 : 16S - 16S
  • [38] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [39] Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis
    Tyring, Stephen
    Gordon, Kenneth B.
    Poulin, Yves
    Langley, Richard G.
    Gottlieb, Alice B.
    Dunn, Meleana
    Jahreis, Angelika
    ARCHIVES OF DERMATOLOGY, 2007, 143 (06) : 719 - 726
  • [40] Long term efficacy and safety of etanercept in psoriasis
    Garcia-Patos Briones, V.
    Mollet Sanchez, J.
    ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 : 12 - 17
12345